Andrea B. Parker, MSc, PhD
She was involved in the organization and execution of many large-scale international clinical trials, specializing in cardiovascular disease, pain management, and imaging techniques. She worked in academic settings, as well as for Contract Research Organisations and for Industry.
Prior to joining Cardiol Therapeutics Inc., she was Chief Scientific Officer at the Peter Munk Cardiac Centre, University Health Network in Toronto, where she provided scientific support for industry-sponsored and investigator-initiated trials, including clinical team and committee management, budget allocation, and grant writing support (2010 – 2019). Dr. Parker also served as Vice President, Clinical Development for Fralex Therapeutic Inc., a medical device company in the therapeutic area of pain management. She held the position Director, Clinical Affairs at Vasogen Inc., where she was responsible for the execution of two pivotal trials, involving more than 200 sites in the U.S., Canada, and Europe. Prior to Vasogen Inc., Dr. Parker was the Managing Director of the offices in Boston and in Toronto for a Contract Research Organization (Société de la Recherche Cardiologique) based in Switzerland. She was responsible for day-to-day management of the company, as well as setting strategic directions for all clinical affairs services. This included building infrastructure and framework to further expand the company’s projects, as well as overseeing staff.
Dr. Parker graduated with a Master of Science degree in Chemistry from the University of Leipzig (Germany); she holds a MSc in Clinical Epidemiology from Harvard School of Public Health and a PhD in Medical Sciences from the University of Toronto.